Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 7
2005 4
2006 8
2007 10
2008 14
2009 17
2010 18
2011 12
2012 13
2013 19
2014 23
2015 19
2016 12
2017 24
2018 15
2019 14
2020 22
2021 17
2022 19
2023 14
2024 18
2025 25
2026 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
Sanyal AJ, Bedossa P, Fraessdorf M, Neff GW, Lawitz E, Bugianesi E, Anstee QM, Hussain SA, Newsome PN, Ratziu V, Hosseini-Tabatabaei A, Schattenberg JM, Noureddin M, Alkhouri N, Younes R; 1404-0043 Trial Investigators. Sanyal AJ, et al. N Engl J Med. 2024 Jul 25;391(4):311-319. doi: 10.1056/NEJMoa2401755. Epub 2024 Jun 7. N Engl J Med. 2024. PMID: 38847460 Free article. Clinical Trial.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Inducing and exploiting vulnerabilities for the treatment of liver cancer.
Wang C, Vegna S, Jin H, Benedict B, Lieftink C, Ramirez C, de Oliveira RL, Morris B, Gadiot J, Wang W, du Chatinier A, Wang L, Gao D, Evers B, Jin G, Xue Z, Schepers A, Jochems F, Sanchez AM, Mainardi S, Te Riele H, Beijersbergen RL, Qin W, Akkari L, Bernards R. Wang C, et al. Among authors: sanchez am. Nature. 2019 Oct;574(7777):268-272. doi: 10.1038/s41586-019-1607-3. Epub 2019 Oct 2. Nature. 2019. PMID: 31578521 Free PMC article.
Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.
Kaplan LM, Startseva E, le Roux CW, Wharton S, Bozkurt B, Mazo DF, von Schlippenbach J, González Maldonado S, Ajaz Hussain S, Neff GW, Gonzalez Rojas Y, Smith C, Younes R, Sanyal AJ; SYNCHRONIZE-MASLD Investigators. Kaplan LM, et al. Nat Med. 2026 Aug;32(8):2948-2958. doi: 10.1038/s41591-026-04479-3. Epub 2026 Jun 7. Nat Med. 2026. PMID: 42252333 Free PMC article. Clinical Trial.
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).
Clark VC, Strange C, Strnad P, Sanchez AJ, Kwo P, Pereira VM, van Hoek B, Barjaktarevic I, Corsico AG, Pons M, Goldklang M, Gray M, Kuhn B, Vargas HE, Vierling JM, Vuppalanchi R, Brantly M, Kappe N, Chang T, Schluep T, Zhou R, Hamilton J, San Martin J, Loomba R. Clark VC, et al. Among authors: sanchez aj. Gastroenterology. 2024 Oct;167(5):1008-1018.e5. doi: 10.1053/j.gastro.2024.06.028. Epub 2024 Jul 2. Gastroenterology. 2024. PMID: 38964420 Free article. Clinical Trial.
Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.
Muñoz AJ, Souto JC, Lecumberri R, Obispo B, Sanchez A, Aparicio J, Aguayo C, Gutierrez D, Palomo AG, Fanjul V, Del Rio-Bermudez C, Viñuela-Benéitez MC, Hernández-Presa MÁ. Muñoz AJ, et al. Among authors: sanchez a. Thromb Res. 2023 Aug;228:181-188. doi: 10.1016/j.thromres.2023.06.015. Epub 2023 Jun 16. Thromb Res. 2023. PMID: 37348318 Free article.
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease.
Loomba R, Clark VC, Mandorfer M, Miravitlles M, Brantly M, Karpen SJ, Krag A, Kwo PY, Rockey DC, Russo MW, Sanchez AJ, Santarella S, Sharpton SR, Strange C, Teckman JH, Turner AM, Vargas HE, Strnad P. Loomba R, et al. Among authors: sanchez aj. Gastroenterology. 2026 Apr;170(4):829-842. doi: 10.1053/j.gastro.2025.12.012. Epub 2025 Dec 11. Gastroenterology. 2026. PMID: 41390004
Effusive-constrictive pericarditis.
Sagristà-Sauleda J, Angel J, Sánchez A, Permanyer-Miralda G, Soler-Soler J. Sagristà-Sauleda J, et al. Among authors: sanchez a. N Engl J Med. 2004 Jan 29;350(5):469-75. doi: 10.1056/NEJMoa035630. N Engl J Med. 2004. PMID: 14749455 Free article.
Metabolite perturbations in type 1 diabetes associated with metabolic dysfunction-associated steatotic liver disease.
Taiwo A, Merrill RA, Wendt L, Pape D, Thakkar H, Maschek JA, Cox J, Summers SA, Chaurasia B, Pothireddy N, Carlson BB, Sanchez A, Ten Eyck P, Jalal D, Dokun A, Taylor EB, Sivitz WI. Taiwo A, et al. Among authors: sanchez a. Front Endocrinol (Lausanne). 2025 Jun 3;16:1500242. doi: 10.3389/fendo.2025.1500242. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40568565 Free PMC article.
322 results